Results

Total Results: 2,463 records

Showing results for "testing".

261. Future Research Needs for Diagnosis of Obstructive Sleep Apnea (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
     February 01, 2012 - full testing alone? … Indications (patient signs, symptoms, or other features) for appropriate home testing 7. … Randomized trials of phased testing 17. … How does phased testing (screening tests or battery followed by full test) compare to full testing … Randomized trials of phased testing 17.

262. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
     January 01, 2013 - ; however, the evidence for the potential harms associated with testing or test-associated treatment … What are the adverse effects or harms associated with testing using newer and/or older markers of … Studies did not attribute these deaths to either testing or any treatment. … The major burden would be additional testing as per protocol. … A randomized trial of iron deficiency testing strategies in hemodialysis patients.

263. Screening for Glaucoma: Comparative Effectiveness | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/glaucoma-screening/research
     April 12, 2012 - retina tomograph (HRT), and lower than disc photos or frequency doubling technology (FDT) visual field testing

264. Effectiveness of Early Diagnosis, Prevention, and Treatment of Clostridium difficile Infection (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
     March 01, 2012 - REVISED TEXT: For diagnostic testing, direct comparisons of commercially available enzyme immunoassays … In my own experience when a laboratory moves from testing any sample to only testing loose stools the … This sentence seems to imply testing of isolates, and therefore culture for C. difficile, is common … REVISED TEXT; Cytotoxicity testing is not a perfectly accurate gold standard. … No statistical testing between groups was conducted. Peer Reviewer #4 Results Page 87.

265. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-risk-bias.ppt
     June 01, 2012 - don’t know status” are excluded and do not have their disease status verified (no reference standard testing … Relatives who are DECEASED are excluded from having any verification undertaken (no reference standard testing … Relatives who are UNABLE TO PARTICIPATE in interviews or further clinical testing are excluded from having … any verification method (no reference standard testing).

266. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-risk-bias.ppt
     June 01, 2012 - don’t know status” are excluded and do not have their disease status verified (no reference standard testing … Relatives who are DECEASED are excluded from having any verification undertaken (no reference standard testing … Relatives who are UNABLE TO PARTICIPATE in interviews or further clinical testing are excluded from having … any verification method (no reference standard testing).

267. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_executive.pdf
     July 01, 2011 - How does phased testing (screening tests or battery followed by full test) compare to full testing alone … How does phased testing (screening tests or battery followed by full test) compare to full testing alone … The strength of evidence is insufficient to determine the utility of phased testing, followed by full … • Trials are needed comparing potential phased testing strategies with direct PSG or addressing the … , but had substantial verification bias due to Phased testing implementation of the phased testing

268. Colorectal-Cancer-Protocol_130520 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
     May 20, 2013 - Services Task Force currently recommends screening for colorectal cancer using fecal occult blood testing … Staging Systems Once the diagnosis has been established, patients with colorectal cancer undergo testing … The differences in the testing protocols associated with different imaging modalities can affect their … Intermediate outcomes such as test performance and harms of testing can be measured immediately after … For questions about the impact of testing on patient-oriented clinical outcomes, comparative studies

269. Liver-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer_research-protocol.pdf
     July 24, 2013 - Surveillance is the use of periodic testing to monitor lesions in the liver that give rise to a clinical … What are the adverse effects or harms associated with using imaging techniques related to testing or …  Psychosocial effects of diagnostic testing on patients, patients’ caregivers, and other family …  Psychosocial effects of diagnostic testing on patients, patients’ caregivers, and other family …  Psychosocial effects of diagnostic testing on patients, patients’ caregivers, and other family

270. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
     December 31, 2022 - What are the unintended consequences of antibody testing after SARS-CoV-2 infection? … Currently, the most salient use of antibody testing is as a correlate of protection against infection … This review does not address all potential uses of antibody testing in clinical practice. … Most notably, this review does not address the use of antibody testing for the diagnosis of SARS-CoV … Current Testing Strategies for SARS-CoV-2 in the United States.

271. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-intro.ppt
     June 01, 2012 - A causal chain diagram can be used to illustrate the steps from the testing phase to the point that a

272. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-intro.ppt
     June 01, 2012 - A causal chain diagram can be used to illustrate the steps from the testing phase to the point that a

273. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-options-summarizing.ppt
     June 01, 2012 - Studies have shown that PSA testing is prone to misclassification error. … These include when a new method of testing is an improved version of the usually applied test.

274. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-options-summarizing.ppt
     June 01, 2012 - Studies have shown that PSA testing is prone to misclassification error. … These include when a new method of testing is an improved version of the usually applied test.

275. Methods Guide for Medical Test Reviews Chapter 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-introduction_methods.pdf
     July 01, 2012 - Methods Guide for Medical Test Reviews Chapter 1 1-1 Chapter 1 Introduction to the Methods Guide for Medical Test Reviews David B. Matchar, M.D., FACP, FAHA; Duke-NUS Graduate Medical School Singapore; Duke University Medical Center, Durham, NC Abstract Evaluation of medical tests presents cha…

276. C-Diff-Infections-Surveillance-140925 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
     January 01, 2014 - The diagnostic testing mechanisms, preventative interventions, treatment medications, and adjunctive … algorithm would have been missed if only EIA for toxin testing had been performed. … The authors suggest that these findings suggest that the use of PCR-based CDI testing methods could … difficile testing by PCR assay (LC- CDTX assay) were used to compare three molecular assays. … Diff Quik Chek Complete assay with reflex to Xpert C. difficile PCR testing for discrepant results

277. Localized Prostate Cancer | Effective Health Care
     effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/index.html
     June 08, 2018 - by a biopsy and appears to be only located completely inside the prostate gland (based on available testing

278. Localized Prostate Cancer | Effective Health Care
     effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/02.html
     June 08, 2018 - Information about treatment options that may be available to you based on available testing.

279. Development and Implementation of Secure Statistical Analyses on Distributed Databases | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/dsitributed-database-analyses/abstract
     July 28, 2010 - Thorough testing of the macros will be conducted to ensure the accuracy of the results.

280. Comparative Effectiveness of Non-Invasive Diagnostic Tests for Breast Abnormalities – An Update of a 2006 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/breast-abnormalities-tests-update/research-protocol
     June 28, 2010 - Positive predictive value: the probability of a woman actually having breast cancer after testing positive … Negative predictive value: the probability of a woman actually not having breast cancer after testing